Shi Haoyue, Zhao Tianzi, Li Yanjun, Xiao Xiang, Wu Jiayun, Zhang Haojun, Qiao Jiajun, Huang Li, Li Lin
Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Cardiovascular Internal Medicine, Affiliated Hospital of Hebei University of Traditional Chinese Medicine, Shijiazhuang, China.
Front Pharmacol. 2021 Apr 30;12:621194. doi: 10.3389/fphar.2021.621194. eCollection 2021.
Velvet antler (VA; cornu cervi pantotrichum), a well-known traditional Chinese medicine, has been shown to exert cardioprotective effects. The purpose of this study was to investigate the effect of VA on heart failure (HF) caused by ischemia-reperfusion, and explore its possible mechanism from the regulation of sarcoplasmic/endoplasmic reticulum Ca-ATPase 2 alpha (SERCA2a). A rat model of HF was established by ligating the left anterior descending coronary artery of male Sprague-Dawley rats ( = 88). One week after surgery, VA (200, 400, or 800 mg/[kg day]) or enalapril (1 mg/[kg day]) was administered daily for the next 4 weeks. Heart function was detected by echocardiography and histopathological analysis. The serum BNP level was measured by ELISA, and the expression of SERCA2a, PLB, PLB-Ser, and PKA was determined by western blotting. SERCA2a and PLB mRNA levels were determined by real-time quantitative PCR. Compared with the sham group, cardiac function in the HF group, including the serum BNP level, heart mass index, myocardial collagen deposition, and left ventricular ejection fraction, was markedly reduced; however, these changes could be reversed by VA treatment. In addition, VA (200 mg/[kg·d]) inhibited the decrease of SERCA2a and PLB mRNA levels and SERCA2a, PLB, PLB-Ser, and PKA protein expression and restored the activity of SERCA2a and PKA. Enalapril affected only PLB protein expression. VA can improve myocardial fibrosis and ventricular remodeling in rats, thereby helping to restore cardiac function. The underlying mechanism may be related to the upregulation of the expression and activation of PKA and PLB and the restoration of the expression and activity of SERCA2a.
鹿茸(VA;鹿茸)是一种著名的传统中药,已被证明具有心脏保护作用。本研究的目的是探讨VA对缺血再灌注引起的心力衰竭(HF)的影响,并从肌浆网/内质网Ca-ATP酶2α(SERCA2a)的调节方面探讨其可能的机制。通过结扎雄性Sprague-Dawley大鼠(n = 88)的左冠状动脉前降支建立HF大鼠模型。手术后1周,在接下来的4周内每天给予VA(200、400或800mg/[kg·天])或依那普利(1mg/[kg·天])。通过超声心动图和组织病理学分析检测心脏功能。通过ELISA测定血清BNP水平,并通过蛋白质印迹法测定SERCA2a、PLB、PLB-Ser和PKA的表达。通过实时定量PCR测定SERCA2a和PLB mRNA水平。与假手术组相比,HF组的心脏功能,包括血清BNP水平、心脏质量指数、心肌胶原沉积和左心室射血分数,均明显降低;然而,VA治疗可逆转这些变化。此外,VA(200mg/[kg·d])抑制SERCA2a和PLB mRNA水平以及SERCA2a、PLB、PLB-Ser和PKA蛋白表达的降低,并恢复SERCA2a和PKA的活性。依那普利仅影响PLB蛋白表达。VA可以改善大鼠的心肌纤维化和心室重构,从而有助于恢复心脏功能。其潜在机制可能与PKA和PLB的表达和激活上调以及SERCA2a的表达和活性恢复有关。